Royal Marsden NHS Foundation Trust: Precision Treatment Helps High Risk Blood Cancer Patients Live Longer, Research Shows
September 09, 2026
September 09, 2026
LONDON, England, Sept. 9 (TNSjou) -- The Royal Marsden National Health Service Foundation Trust issued the following news:
* * *
Precision treatment helps high risk blood cancer patients live longer, research shows
Patients with the most aggressive forms of the blood cancer multiple myeloma can live significantly longer when their treatment is tailored to their disease, according to new long term results from a major UK led clinical trial.
Lo . . .
* * *
Precision treatment helps high risk blood cancer patients live longer, research shows
Patients with the most aggressive forms of the blood cancer multiple myeloma can live significantly longer when their treatment is tailored to their disease, according to new long term results from a major UK led clinical trial.
Lo . . .